Immunosurveillance and cancer: epidemiological evidence.
作者信息
Doll R, Kinlen L
出版信息
Br Med J. 1970 Nov 14;4(5732):420-2. doi: 10.1136/bmj.4.5732.420.
Abstract
摘要
相似文献
1
Immunosurveillance and cancer: epidemiological evidence.免疫监视与癌症：流行病学证据
Br Med J. 1970 Nov 14;4(5732):420-2. doi: 10.1136/bmj.4.5732.420.
2
[Significance of immunologic defects for neoplasm development].
Internist (Berl). 1977 May;18(5):264-8.
3
[Immunological surveillance and spontaneous carcinogenesis].[免疫监视与自发癌变]
Ann Inst Pasteur (Paris). 1972 Apr;122(4):669-75.
4
Occurrence of malignancy in immunodeficiency diseases. A literature review.免疫缺陷疾病中的恶性肿瘤发生情况。文献综述。
Cancer. 1971 Jul;28(1):89-98. doi: 10.1002/1097-0142(197107)28:1<89::aid-cncr2820280117>3.0.co;2-q.
5
Malignant neoplasms in registered cases of primary immunodeficiency syndrome.
Jpn J Clin Oncol. 1985 Apr;15 Suppl 1:307-12.
6
Cutaneous manifestations of immunogenetic deficiency disorders.免疫遗传学缺陷疾病的皮肤表现
Birth Defects Orig Artic Ser. 1981;17(2):93-115.
7
[Relationship between thymectomy and syndrome differentiation-typing treatment of myasthenia gravis].胸腺切除术与重症肌无力辨证论治的关系
Zhongguo Zhong Xi Yi Jie He Za Zhi. 1995 Sep;15(9):525-7.
8
Primary immunodeficiency diseases and malignancy in Japan.日本的原发性免疫缺陷疾病与恶性肿瘤
Jpn J Cancer Res. 1986 Jan;77(1):74-9.
9
Thymectomy for myasthenia gravis: evaluation of results in 282 patients.重症肌无力的胸腺切除术：282例患者的结果评估
Rev Hosp Clin Fac Med Sao Paulo. 1992 May-Jun;47(3):117-20.
10
[Surgical treatment of myasthenia gravis].[重症肌无力的外科治疗]
Zhonghua Shen Jing Jing Shen Ke Za Zhi. 1987 Oct;20(5):283-5.
引用本文的文献
1
Lung cancer incidences after liver transplantation: A systematic review and meta-analysis.肝移植后肺癌的发病率：系统评价和荟萃分析。
Cancer Med. 2023 Aug;12(15):16119-16128. doi: 10.1002/cam4.6265. Epub 2023 Jun 23.
2
Systemic inflammatory changes and their clinical implications following thoracic cancer surgery.胸段食管癌术后全身炎症反应变化及其临床意义
Indian J Thorac Cardiovasc Surg. 2022 Sep;38(5):487-496. doi: 10.1007/s12055-021-01301-2. Epub 2022 Mar 23.
3
Malignancy: An Adverse Effect of Immunosuppression.恶性肿瘤：免疫抑制的不良反应。
Handb Exp Pharmacol. 2022;272:315-335. doi: 10.1007/164_2021_554.
4
Emerging Role and Future Directions of Immunotherapy in Advanced Ovarian Cancer.免疫疗法在晚期卵巢癌中的新兴作用及未来方向
Hematol Oncol Clin North Am. 2018 Dec;32(6):1025-1039. doi: 10.1016/j.hoc.2018.07.011. Epub 2018 Oct 1.
5
Current status and future directions of cancer immunotherapy.癌症免疫疗法的现状与未来方向
J Cancer. 2018 Apr 19;9(10):1773-1781. doi: 10.7150/jca.24577. eCollection 2018.
6
Harnessing immunosurveillance: current developments and future directions in cancer immunotherapy.利用免疫监视：癌症免疫治疗的当前进展与未来方向
Immunotargets Ther. 2014 Dec 4;3:151-65. doi: 10.2147/ITT.S37790. eCollection 2014.
7
Recent advances and future of immunotherapy for glioblastoma.胶质母细胞瘤免疫治疗的最新进展和未来。
Expert Opin Biol Ther. 2016 Oct;16(10):1245-64. doi: 10.1080/14712598.2016.1212012. Epub 2016 Jul 27.
8
Insight to drug delivery aspects for colorectal cancer.结直肠癌药物递送方面的见解。
World J Gastroenterol. 2016 Jan 14;22(2):582-99. doi: 10.3748/wjg.v22.i2.582.
9
Overview of current immunotherapeutic strategies for glioma.胶质瘤当前免疫治疗策略概述
Immunotherapy. 2015;7(10):1073-104. doi: 10.2217/imt.15.75.
10
Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine.类风湿关节炎患者的死亡原因，特别提及硫唑嘌呤。
Ann Rheum Dis. 1980 Oct;39(5):457-61. doi: 10.1136/ard.39.5.457.
本文引用的文献
1
Occurrence of leukemia and lymphoma in patients with agammaglobulinemia.无丙种球蛋白血症患者中白血病和淋巴瘤的发生情况。
Blood. 1963 Feb;21:197-206.
2
Mortality from lung cancer and other causes among workers in an asbestos textile factory.一家石棉纺织厂工人中肺癌及其他原因导致的死亡率
Br J Ind Med. 1968 Oct;25(4):293-303. doi: 10.1136/oem.25.4.293.
Zotero 插件